Overview

Efficacy of HUMIRA in Subjects With Active Rheumatoid Arthritis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to assess the efficacy of adalimumab in subjects with rheumatoid arthritis focusing on subject-reported outcomes and early response to treatment
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Abbott
Treatments:
Adalimumab
Criteria
Inclusion Criteria:

- Subject was age 18 or older and in good health (Investigator discretion) with a recent
stable medical history.

- Subject, based on assessment of investigator, meets the definition of active RA

Exclusion Criteria:

- Subject considered by the investigator, for any reason, to be an unsuitable candidate
for the study

- Female subject who is pregnant or breast-feeding or considering becoming pregnant